Literature DB >> 1482127

Continuous infusion of beta-lactam antibiotics.

W A Craig1, S C Ebert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1482127      PMCID： PMC245510          DOI： 10.1128/AAC.36.12.2577

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  65 in total

1.  The Action of Penicillin on Staphylococcus: Further Observations on the Effect of a Short Exposure.

Authors:  R F Parker; S Luse
Journal:  J Bacteriol       Date:  1948-07       Impact factor: 3.490

2.  BACTERIOSTATIC AND LYTIC ACTIONS OF PENICILLIN ON SENSITIVE AND RESISTANT STAPHYLOCOCCI.

Authors:  W M Kirby
Journal:  J Clin Invest       Date:  1945-03       Impact factor: 14.808

3.  The influence of the dosage regimen on the therapeutic effectiveness of penicillin G in experimental lobar pneumonia.

Authors:  L H SCHMIDT; A WALLEY
Journal:  J Pharmacol Exp Ther       Date:  1951-12       Impact factor: 4.030

4.  The bactericidal action of penicillin in vivo: the participation of the host, and the slow recovery of the surviving organisms.

Authors:  H EAGLE; R FLEISCHMAN; A D MUSSELMAN
Journal:  Ann Intern Med       Date:  1950-09       Impact factor: 25.391

5.  Kinetics of cephaloridine in experimental wounds.

Authors:  H P Ehrlich; V Licko; T K Hunt
Journal:  Am J Med Sci       Date:  1973-01       Impact factor: 2.378

6.  Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumoniae pneumonia in rats.

Authors:  R Roosendaal; I A Bakker-Woudenberg; J C van den Berg; M F Michel
Journal:  J Infect Dis       Date:  1985-08       Impact factor: 5.226

7.  Combination antibiotic therapy: comparison of constant infusion and intermittent bolus dosing in an experimental animal model.

Authors:  J J Mordenti; R Quintiliani; C H Nightingale
Journal:  J Antimicrob Chemother       Date:  1985-01       Impact factor: 5.790

8.  Effect of storage of penicillin-G solutions on sensitisation to penicillin-G after intravenous administration.

Authors:  K A Neftel; M Wälti; H Spengler; A L de Weck
Journal:  Lancet       Date:  1982-05-01       Impact factor: 79.321

9.  Time course of the pharmacological response to beta-lactam antibiotics in vitro and in vivo.

Authors:  A U Gerber; C Feller; H P Brugger
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

10.  Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae.

Authors:  M G Täuber; C A Doroshow; C J Hackbarth; M G Rusnak; T A Drake; M A Sande
Journal:  J Infect Dis       Date:  1984-04       Impact factor: 5.226
View more
  73 in total

Review 1.  Comparative pharmacokinetics of the carbapenems: clinical implications.

Authors:  J W Mouton; D J Touzw; A M Horrevorts; A A Vinks
Journal:  Clin Pharmacokinet       Date:  2000-09       Impact factor: 6.447

2.  Nonlinear pharmacokinetics of piperacillin in healthy volunteers--implications for optimal dosage regimens.

Authors:  Jürgen B Bulitta; Martina Kinzig; Verena Jakob; Ulrike Holzgrabe; Fritz Sörgel; Nicholas H G Holford
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

Review 3.  The treatment of staphylococcal infections with special reference to pharmacokinetic, pharmacodynamic and pharmacoeconomic considerations.

Authors:  R Janknegt
Journal:  Pharm World Sci       Date:  1997-06

4.  Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection.

Authors:  William K Lau; David Mercer; Kamal M Itani; David P Nicolau; Joseph L Kuti; Debra Mansfield; Adrian Dana
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

5.  Population pharmacokinetics at two dose levels and pharmacodynamic profiling of flucloxacillin.

Authors:  Cornelia B Landersdorfer; Carl M J Kirkpatrick; Martina Kinzig-Schippers; Jürgen B Bulitta; Ulrike Holzgrabe; George L Drusano; Fritz Sörgel
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

6.  Continuous cefazolin infusion to treat bone and joint infections: clinical efficacy, feasibility, safety, and serum and bone concentrations.

Authors:  Valérie Zeller; Frédérick Durand; Marie-Dominique Kitzis; Luc Lhotellier; Jean-Marc Ziza; Patrick Mamoudy; Nicole Desplaces
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

7.  Efficacious Analogs of the Lantibiotic Mutacin 1140 against a Systemic Methicillin-Resistant Staphylococcus aureus Infection.

Authors:  Mengxin Geng; Akshaya Ravichandran; Jerome Escano; Leif Smith
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

8.  Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units).

Authors:  Eric Viaene; Hugues Chanteux; Hélène Servais; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 9.  Meropenem clinical pharmacokinetics.

Authors:  J W Mouton; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

10.  Continuous infusion of ceftazidime in febrile neutropenic patients with acute myeloid leukemia.

Authors:  S Daenen; Z Erjavec; D R Uges; H G De Vries-Hospers; P De Jonge; M R Halie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.